AGIOS PHARMACEUTICALS, INC. (AGIO) Total liabilities 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) total liabilities at each fiscal year-end, per SEC filings.
$104.1MFY2025 · since FY2016: $260.5M → $104.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.1M | -14.8% |
| FY2024 | $122.2M | -3.1% |
| FY2023 | $126.1M | -8.6% |
| FY2022 | $137.9M | -5.4% |
| FY2021 | $145.8M | -67.9% |
| FY2020 | $453.5M | +81.2% |
| FY2019 | $250.2M | +46.4% |
| FY2018 | $170.9M | -28.5% |
| FY2017 | $238.9M | -8.3% |
| FY2016 | $260.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice